Skip to main content

Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial.

Publication ,  Journal Article
Fu, Y; Goodman, S; Chang, WC; Van De Werf, F; Granger, CB; Armstrong, PW
Published in: Circulation
November 27, 2001

BACKGROUND: Early ST resolution after reperfusion is a prognostic indicator in acute myocardial infarction. Little information exists regarding the prognostic utility of ST resolution beyond 4 hours after fibrinolysis. Furthermore, the relation between time to treatment, ST resolution at 24 to 36 hours, and 1-year outcome has not been well studied. Accordingly, we undertook a prospective ECG substudy in the Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) trial to examine this. METHODS AND RESULTS: Patients (n=13 100) were stratified into 3 ST-resolution categories, based on baseline and 24- to 36-hour ECGs: complete resolution (>/=70%) in 6698 (51.1%) patients, partial resolution (30% to 70%) in 4610 (35.2%) patients, and no resolution (<30%) in 1792 (13.7%) patients; 1-year mortality rate was 5.1%, 8.0%, and 9.7%, respectively (P<0.001). Among patients treated <2 hours after symptom onset, 55.6% had complete ST resolution, whereas 52.1% and 43% of patients treated between 2 to 4 hours and 4 to 6 hours, respectively, had complete ST resolution (P<0.001). Within each category of ST resolution, patients treated <2 hours had lower 1-year mortality rates as compared with patients treated between 2 to 4 hours or >4 hours (3.8% versus 5.2% and 6.6%, P=0.002 in complete ST resolution; 5.7% versus 8.4% and 9.9%, P=0.001 in partial ST resolution; 7.1% versus 8.7% and 13%, P=0.006 in no resolution). The extent of ST resolution was closely and inversely correlated with 1-year mortality rates (r=-0.963, P<0.001). CONCLUSIONS: ST resolution at 24 to 36 hours after fibrinolysis is influenced by time to treatment and inversely related to 1-year mortality rates. Time to treatment further differentiates between high- and low-risk patients and further highlights the importance of reducing time delay to initiation of fibrinolysis in acute myocardial infarction.

Duke Scholars

Altmetric Attention Stats
Dimensions Citation Stats

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

November 27, 2001

Volume

104

Issue

22

Start / End Page

2653 / 2659

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Time
  • Thrombolytic Therapy
  • Tenecteplase
  • Survival Rate
  • Risk
  • Prospective Studies
  • Proportional Hazards Models
  • Prognosis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Fu, Y., Goodman, S., Chang, W. C., Van De Werf, F., Granger, C. B., & Armstrong, P. W. (2001). Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial. Circulation, 104(22), 2653–2659. https://doi.org/10.1161/hc4701.099731
Fu, Y., S. Goodman, W. C. Chang, F. Van De Werf, C. B. Granger, and P. W. Armstrong. “Time to treatment influences the impact of ST-segment resolution on one-year prognosis: insights from the assessment of the safety and efficacy of a new thrombolytic (ASSENT-2) trial.Circulation 104, no. 22 (November 27, 2001): 2653–59. https://doi.org/10.1161/hc4701.099731.

Published In

Circulation

DOI

EISSN

1524-4539

Publication Date

November 27, 2001

Volume

104

Issue

22

Start / End Page

2653 / 2659

Location

United States

Related Subject Headings

  • Treatment Outcome
  • Tissue Plasminogen Activator
  • Time
  • Thrombolytic Therapy
  • Tenecteplase
  • Survival Rate
  • Risk
  • Prospective Studies
  • Proportional Hazards Models
  • Prognosis